MoneyWorks4Me

Glenmark Pharmaceuticals submits disclosure

21 Mar 2014 Evaluate

Glenmark Pharmaceuticals has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma. Share Price

2456.80 16.80 (0.69%)
27-Aug-2026 12:31 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.40
Dr. Reddys Labs. 1185.65
Cipla 1410.15
Lupin 2183.95
Zydus Lifesciences 1173.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: